Binding of Platelet Agglutinating Protein p 37 from the Plasma of a Patient with Thrombotic Thrombocytopenic Purpura to Human Platelets

Eric C-Y Lian; Farooq A Siddiqui

doi:10.1055/s-0038-1647461

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1991; 65(01): 096-101
DOI: 10.1055/s-0038-1647461

Original Article

Schattauer GmbH Stuttgart

Binding of Platelet Agglutinating Protein p 37 from the Plasma of a Patient with Thrombotic Thrombocytopenic Purpura to Human Platelets

Eric C-Y Lian

The Hemophilia and Thrombosis Center, W. J. Harrington Center for Blood Diseases, University of Miami School of Medicine and the Research and Medical Services, Veterans Administration Medical Center, Miami, Florida, USA

,

Farooq A Siddiqui

The Hemophilia and Thrombosis Center, W. J. Harrington Center for Blood Diseases, University of Miami School of Medicine and the Research and Medical Services, Veterans Administration Medical Center, Miami, Florida, USA

› Author Affiliations

Abstract

PDF Download

Summary

We have previously reported the purification of a 37 kDa platelet agglutinating protein (PAP p37) from the plasma of a patient with thrombotic thrombocytopenic purpura (TTP) that was shown to be present in a subset of TTP patients. To gain further insight into the interaction between PAP p37 and platelets, we have studied the properties of PAP p37 binding to platelets. Washed human platelets from two normal donors and two TTP patients after recovery were used for the experiments. The PAP p 37 binding to platelets was specific, concentration dependent and saturable. Scatchard analysis demonstrated about 20,564–27,090 PAP p37 binding sites per platelet. Stimulation of platelets with thrombin or ADP did not have any significant effect on its binding.

Thiol- and serine-specific protease inhibitors did not inhibit PAP p37 binding to the platelets. Sugars such as glucose, fructose, mannose, and sialic acid, at 40 mM, inhibited its binding to platelets by 44%, 73%, 79%, and 91% respectively, but galactose and amino sugars did not have any significant effect. At 250 μg/ml, Concanavalin-A inhibited 42% of binding, but other lectins, such as phytohemagglutinin-P, potato lectin and helix pomatia lectin (snail), did not. Pre-incubation of ¹²⁵I-PAP p37 with the adult human IgG, decreased its binding to the platelets. The monoclonal antibodies to GP Ib (6D1) and GP IIb-IIIa complex (10E5) did not inhibit the binding of ¹²⁵I-PAP p37 to platelets. Fibrinogen and von Willebrand factor did not affect the binding either. These results suggest that PAP p37 binds to platelets on the sites other than GP lb or GP IIb-IIIa complex.

PDF (1227 kb)

References

References
1 Moschcowitz E. An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries: An undescribed disease. Arch Int Med 1925; 36: 89-93
2 Amorosi EL, Ultman JE. Thrombotic thrombocytopenic purpura: Report of 16 cases and review of literature. Medicine (Baltimore) 1966; 45: 139-159
3 Kwaan HC. The pathogenesis of thrombotic thrombocytopenic purpura. Semin Thromb Hemostas 1979; 3: 184-198
4 Myers TJ, Wakem CJ, Ball ED, Tremont SJ. Thrombotic thrombocytopenic purpura: Combined treatment with plasmapheresis and anti-platelet agents. Ann Intern Med 1980; 92: 149-155
5 Lian EC-Y, Harkness DR, Byrnes JJ, Wallach H, Nunez R. The presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura and its inhibition by normal plasma. Blood 1979; 53: 333-338
6 Ansell J, Slepchuck NI, Pechet L. Thrombotic thrombocytopenic purpura. Blood 1979; 54: 959-960
7 Brandt JT, Kennedy MS, Senhauser DA. Platelet aggregating factor in thrombotic thrombocytopenic purpura. Lancet 1979; 2: 463-464
8 Burnes ER, Zucker-Franklin D. Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells. Blood 1982; 60: 1030-1037
9 Kelton JG, Moore J, Santos A, Sheridan D. Detection of a platelet-agglutinating factor in thrombotic thrombocytopenic purpura. Ann Intern Med 1984; 101: 589-593
10 Lian EC-Y, Savaraj N. Effects of platelet inhibitors on the platelet aggregation induced by plasma from patients with thrombotic thrombocytopenic purpura. Blood 1981; 58: 354-359
11 Lian EC-Y, Mui P, Siddiqui FA, Chiu AY, Chiu LL. Inhibition of platelet aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G. J Clin Invest 1984; 73: 548-555
12 Siddiqui FA, Lian EC-Y. Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma. J Clin Invest 1985; 76: 1330-1337
13 Fowler WE, Fretto LJ, Hamilton KK, Erickson HP, McKee PA. Substructure of human von Willebrand factor. J Clin Invest 1985; 76: 1491-1500
14 Walsh PN, Mills D CB, White JG. Metabolism and function of human platelets washed by albumin density gradient separation. Br J Haematol 1977; 36: 287-296
15 Sinha D, Seaman FS, Koshy A, Knight LC, Walsh PN. Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI. J Clin Invest 1984; 73: 1550-1556
16 Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72: 248-254
17 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 1970; 227: 680-685
18 Lian EC-Y. Pathogenesis of thrombotic thrombocytopenic purpura. Semin Hematol 1987; 24: 82-100
19 Siddiqui FA, Lian EC-Y. Platelet-agglutinating protein p37 from a thrombotic thrombocytopenic purpura plasma forms a complex with human immunoglobulin G. Blood 1988; 71: 299-304
20 Phillips DR, Jakabova M. Calcium dependent protease in human platelets. Specific cleavage of platelet polypeptides in the presence of added Ca⁺⁺ . J Biol Chem 1977; 252: 5602-5605
21 White GC. Calcium-dependent proteins in platelets: Response of calcium-activated protease in normal and thrombasthenic platelets to aggregating agents. Biochim Biophys Acta 1980; 631: 130-138
22 Truglia JA, Stracher A. Purification and characterization of a calcium dependent sulfhydryl protease from human platelets. Biochem Biophys Res Commun 1981; 100: 814-822
23 Yoshida N, Weskler B, Nachman R. Purification of human platelet calcium-activated protease. Effect on platelet and endothelial function. J Biol Chem 1983; 258: 7168-7174
24 Fox JE, Reynolds CC, Phillips DR. Calcium-dependent proteolysis occurs during platelet aggregation. J Biol Chem 1983; 258: 9973-9981
25 Vassalli P, Simon G, Rouiller C. Ultrastructural study of platelet changes initiated in vivo by thrombin. J Ultrastruct Res 1964; 11: 374-387
26 Packham MA, Kinglough-Rathbone RL, Reimers HJ. et al Mechanisms of platelet aggregation independent of adenosine diphosphate. In: Prostaglandins in Hematology Silver MJ. et al. (eds) Spectrum; New York: 1977: 247-276
27 Nachman RL, Leung LL. Complex formation of platelet membrane glycoproteins lib and Ilia with fibrinogen. J Clin Invest 1982; 69: 263-269
28 Kinglough-Rathbone RL, Packham MA, Mustard JF. Effect of amino sugars on platelet aggregation and on fibrinogen binding. Thromb Haemostas 1984; 52: 75-80
29 Scatchard G. The attractions of proteins for small molecules and ions. Ann NY Acid Sci 1949; 51: 660-672
30 Lian EC-Y, Siddiqui FA, Jamieson GA, Tandon NN. Platelet agglutinating protein p37 causes platelet agglutination through its binding to membrane glycoprotein IV. Thromb Haemostas 1991; 65: 102-106